Wyropan IV 40 mg Injection contains Pantoprazole, a proton pump inhibitor (PPI) formulated as a lyophilized powder for intravenous use. It is used for rapid and effective control of gastric acid secretion in patients who require immediate or hospital-based treatment.
Composition
- Pantoprazole – 40 mg (Lyophilized Powder for Injection)
Mechanism of Action
Pantoprazole inhibits the proton pump (H⁺/K⁺ ATPase) in gastric parietal cells, thereby reducing acid production in the stomach. This helps in healing ulcers and relieving symptoms of acid-related disorders.
Key Benefits
- Rapid acid suppression
- Effective in managing severe acidity and reflux
- Suitable for patients unable to take oral medication
- Helps in healing gastric and duodenal ulcers
- Useful in hospital and emergency settings
Indications
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
- Zollinger-Ellison syndrome
- Stress ulcer prophylaxis
- Acid-related disorders in hospitalized patients
Dosage & Administration
- For intravenous use only
- To be administered by a healthcare professional
- Dosage as directed by the physician
Precautions
- Use under medical supervision
- Monitor liver function in long-term use
- Use cautiously in hepatic impairment
Contraindications
- Hypersensitivity to Pantoprazole or other PPIs
Storage
- Store in a cool and dry place below 25°C
- Protect from light
- Keep out of reach of children
Packaging
- 40 mg Vial with diluent for I.V. use
Reviews
There are no reviews yet.